Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer
David Cella*, Lesley Fallowfield, Peter Barker, Jack Cuzick, Gershon Locker, Anthony Howell
Dive into the research topics of 'Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer'. Together they form a unique fingerprint.